74,022 Shares in COPT Defense Properties $CDP Purchased by Jennison Associates LLC

Key Points

• Jennison Associates LLC opened a new position in COPT Defense Properties of 74,022 shares (~$2.06M), representing about 0.07% ownership.
• COPT reported Q1 EPS of $0.34, missing the $0.68 consensus while revenue of $200.6M beat estimates; management set FY2026 guidance of $2.73–$2.79 EPS, roughly in line with analyst expectations of 2.78.
• The company raised its quarterly dividend to $0.32 (annualized $1.28) for a 4.1% yield with a high payout ratio (92.75%), and analysts maintain a consensus Moderate Buy with a $34.38 target.

Jennison Associates LLC bought a new position in shares of COPT Defense Properties (NYSE:CDP - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 74,022 shares of the company's stock, valued at approximately $2,058,000. Jennison Associates LLC owned 0.07% of COPT Defense Properties as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Financial Consulate Inc. acquired a new stake in COPT Defense Properties during the third quarter worth about $39,000. EverSource Wealth Advisors LLC grew its holdings in COPT Defense Properties by 1,176.5% during the second quarter. EverSource Wealth Advisors LLC now owns 1,685 shares of the company's stock worth $46,000 after acquiring an additional 1,553 shares during the period. Optima Capital LLC acquired a new stake in COPT Defense Properties during the fourth quarter worth about $63,000. Osaic Holdings Inc. grew its holdings in COPT Defense Properties by 59.6% during the second quarter. Osaic Holdings Inc. now owns 3,193 shares of the company's stock worth $88,000 after acquiring an additional 1,192 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in COPT Defense Properties by 33.4% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,300 shares of the company's stock worth $92,000 after acquiring an additional 827 shares during the period.

Analyst Ratings Changes

Several analysts have commented on CDP shares. Weiss Ratings raised COPT Defense Properties from a "buy (b-)" rating to a "buy (b)" rating in a report on Tuesday, April 21st. Truist Financial raised their price objective on COPT Defense Properties from $31.00 to $33.00 and gave the company a "hold" rating in a report on Tuesday, March 3rd. Cantor Fitzgerald reissued an "overweight" rating and issued a $37.00 price objective on shares of COPT Defense Properties in a report on Wednesday, April 29th. Evercore reissued an "outperform" rating and issued a $38.00 price objective on shares of COPT Defense Properties in a report on Tuesday, April 28th. Finally, Jefferies Financial Group raised their price objective on COPT Defense Properties from $33.00 to $34.00 and gave the company a "buy" rating in a report on Tuesday, January 27th. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, COPT Defense Properties has a consensus rating of "Moderate Buy" and a consensus target price of $34.38.

Insider Buying and Selling at COPT Defense Properties

In other news, Director Philip L. Hawkins sold 5,536 shares of the firm's stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $32.71, for a total value of $181,082.56. Following the transaction, the director owned 15,188 shares in the company, valued at $496,799.48. This trade represents a 26.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.66% of the stock is currently owned by company insiders.

COPT Defense Properties Stock Down 0.0%

Shares of CDP opened at $31.00 on Monday. The company has a current ratio of 2.85, a quick ratio of 3.95 and a debt-to-equity ratio of 1.63. COPT Defense Properties has a 12 month low of $25.99 and a 12 month high of $33.29. The stock's 50 day moving average is $31.82 and its two-hundred day moving average is $30.34. The firm has a market cap of $3.51 billion, a P/E ratio of 22.46 and a beta of 0.80.

COPT Defense Properties (NYSE:CDP - Get Free Report) last issued its quarterly earnings data on Monday, April 27th. The company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.34). The business had revenue of $200.64 million during the quarter, compared to analyst estimates of $185.10 million. COPT Defense Properties had a net margin of 20.10% and a return on equity of 10.02%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.65 earnings per share. COPT Defense Properties has set its FY 2026 guidance at 2.730-2.790 EPS and its Q2 2026 guidance at 0.680-0.700 EPS. Analysts predict that COPT Defense Properties will post 2.78 earnings per share for the current fiscal year.

COPT Defense Properties Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Tuesday, March 31st were given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 4.1%. This is a boost from COPT Defense Properties's previous quarterly dividend of $0.31. The ex-dividend date was Tuesday, March 31st. COPT Defense Properties's dividend payout ratio (DPR) is 92.75%.

COPT Defense Properties Company Profile

COPT Defense Properties NYSE: CDP is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company's portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.